Involvement of interleukin-18 in patients on maintenance haemodialysis

American Journal of Nephrology

Volumn 22, Issue 5-6, 2002, Pages 417-421

  Gangemi, S ^a   Mallamace, A ^a   Minciullo, P L ^a   Santoro, D ^a   Merendino, R A ^a   Savica, V ^a   Bellinghieri, G ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Dialysis; Interleukin 18; Kt V; Serum; Th1 cells

Indexed keywords

ENZYME; INTERLEUKIN 12; INTERLEUKIN 18;

ADULT; AGE; AGED; ARTICLE; BLOOD LEVEL; CELL DIFFERENTIATION; CELL STRUCTURE; CELL TYPE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HELPER CELL; HEMODIALYSIS; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOASSAY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL;

ADULT; AGED; FEMALE; HUMANS; INTERLEUKIN-18; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0036974486     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065269     Document Type: Article

References (41)

1. Descamps-Latscha B, Jungers P: New molecular aspects of chronic uraemia and dialysis-related immunocompetent cell activation. Nephrol Dial Transplant 1996;11(suppl 2):S121-S124.
2. United States Renal Data System Annual Report. Am J Kidney Dis 1998;32(suppl 1):81-88.
3. Kohler H, Arnold W, Renschin G, Dormeyer HH, Meyer zum Buschenfelde KH: Active hepatitis B vaccination of dialysis patients and medical staff. Kidney Int 1984;25:124-128.
4. Girndt M, Pietsch M, Kohler H: Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure. Am J Kidney Dis 1995;26:454-460.
5. Descamps-Latscha B: The immune system in end-stage renal disease. Curr Opin Nephrol Hypertens 1993;2:883-891.
6. Descamps-Latscha B, Herbelin A, Nguyen A, Zingraff J, Jungers P, Chatenoud L: Immune system dysregulation in uremia. Semin Nephrol 1994;14:253-260.
7. Chatenoud L, Dugas B, Beaurain G: Presence of preactivated T cells in hemodialyzed patients: Their possible role in altered immunity. Proc Natl Acad Sci USA 1986;83:7457-7461.
8. Descamps-Latscha B, Chatenoud L: T cells and B cells in chronic renal failure. Semin Nephrol 1996;16:183-191.
9. Donati D, Degiannis D, Combates N, Raskova J, Raska KJ: Effects of hemodialysis on activation of lymphocytes: Analysis by an in vitro dialysis model. J Am Soc Nephrol 1992;2:1490-1497.
10. Grooteman MPC, Nube MJ: Granulocyte sequestration in dialysers, a comparative study of three different membranes. Nephrol Dial Transplant 1992;10:1859-1864.
11. Abrutyn E, Solomons N: Granulocyte function in patients with chronic renal failure: Surface adherence, phagocytosis and bactericidal activity in vitro. J Infect Dis 1977;135:1-8.
12. Dinarello C, Lonnemann G, Bingel M, Koch K, Shaldon S: Biological consequences of monocyte activation during hemodialysis. Contrib Nephrol 1987;59:1-9.
13. Chatenoud L, Herbelin A, Bearain G, Descamps-Latscha B: Immune deficiency of the uremic patient. Adv Nephrol Necker Hosp 1990;19:259-274.
14. Descamps-Latscha B, Herbelin A: Long-term dialysis and cellular immunity: A critical survey. Kidney Int 1993;41(suppl 2):S135-S142.
15. Lin Y, Chang D, Shaio M, Lu K, Chyr S, Li B, Sheih S: Cytokine production during hemodialysis: Effects of dialytic membrane and complement activation. Am J Nephrol 1993;16:293-299.
16. Himmelfarb J, Zaoui P: Modulation of granulocyte LAM-1 and MAC-1 during dialysis. Kidney Int 1992;41:388-395.
17. Ringoir S, van Looy L, van de Heyning: Impairment of phagocytic activity of macrophages as studied by the skin window test in patients on regular dialysis treatment. Clin Nephrol 1975;4:234-236.
18. Girdt M, Kohler H, Schiedhelm-Weick E, Meyer zum Buschenfelde K, Fleischer B: T cell activation defect in hemodialysis patients: Evidence for a role of the B7/CD28 pathway. Kidney Int 1993;44:359-365.
19. Rabb H, Agosti S, Pollard S, Bittle P, Ramirez G: Activated and regulatory T lymphocyte populations in chronic hemodialysis patients. Am J Kidney Dis 1994;24:443-452.
20. Zamauskaite A, Perez-Cruz IP, Yaqoob MM, Madrigal A, Cohen S: Effect of renal dialysis therapy modality on T cell cytokine production. Nephrol Dial Transplant 1999;14:49-55.
21. Pereira B, Dinarello C: Production of cytokines and cytokine inhibitory proteins in patients on dialysis. Nephrol Dial Transplant 1994;9(suppl 2):60-71.
22. Beaurain G, Naret C, Marcon L: In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients. Kidney Int 1989;36:636-644.
23. Sennesael JJ, Van der Niepen P: Treatment with recombinant erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients. Kidney Int 1991;40:121-128.
24. Meuer SC, Hauer M, Kurz P, Meyer zum Buschenfelde KH, Kohler H: Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses. J Clin Invest 1987;80:743-749.
25. Sester U, Sester M, Hauk M, Kaul H, Kohler H, Girndt M: T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant 2000;15:1217-1223.
26. Swain SL, Helper L: T cell differentiation. Curr Opin Immunol 1999;11:180-185.
27. Klein SA, Ottmann OG, Ballas K, Dobmeyer TS, Pape M, Weidmann E, Hoelzer D, Kalina U: Quantification of human interleukin-18 mRNA expression by competitive reverse transcriptase polymerase chain reaction. Cytokine 1999;11:451-458.
28. Conti B, Park LC, Calingasan NY, Kim Y, Kim H, Bae Y, Gibson G, Joh TH: Cultures of astrocytes and microglia express interleukin 18. Brain Res Mol Brain Res 1999;67:46-52.
29. Sugama S, Kim Y, Baker H, Tinti C, Kim H, Joh TH, Conti B: Tissue-specific expression of rat IL-18 gene and response to adrenocorticotropic hormone treatment. J Immunol 2000;165:6287-6292.
30. Prinz M, Hanisch UK: Murine microglial cells produce and respond to interleukin-18. J Neurochem 1999;72:2215-2218.
31. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM: Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260:547-549.
32. Seder RA, Gazzinelli R, Sher A, Paul WE: IL-12 acts directly on CD4+ T cells to enhance priming for IFN-γ production and diminish IL-4 inhibition of such priming. Proc Natl Acad Sci USA 1993;90:10188-10192.
33. Nockher WA, Scherberich JE: Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect Immun 1998;66:2782-2790.
34. Girndt M, Sester U, Kaul H, Hunger F, Kohler H: Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single cell level. J Am Soc Nephrol 1998;9:1689-1696.
35. Girndt M, Kohler H, Schiedhelm Weick E, Schlaak JF, Meyer zum Buschenfelde KH, Fleischer B: Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int 1995;47:559-565.
36. Dinarello CA: Interleukin-18. Methods 1999;19:121-132.
37. Shigehara K, Shijubo N, Ohmichi M, Takahashi R, Kon S, Okamura H, Kurimoto M, Hiraga Y, Tatsuno T, Abe S, Sato N: IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J Immunol 2001;166:642-649.
38. Chikano S, Sawada K, Shimoyama T, Kashiwamura SI, Sugihara A, Sekikawa K, Terada N, Nakanishi K, Okamura H: IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-gamma dependent manner. Gut 2000;47:779-786.
39. Lauwerys BR, Renauld JC, Houssiau FA: Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18. Cytokine 1999;11:822-830.
40. Kitching RA, Tipping PG, Kurimoto M, Holdsworth S: IL-18 has IL-12-independent effects in delayed-type hypersensitivity: Studies in cell-mediated crescentic glomerulonephritis. J Immunol 2000;165:4649-4657.
41. Barbulescu K, Becker C, Schlaak JF, Schmitt E, Meyer zur Buschenfelde KH, Neurath F: IL-12 and IL-18 differentially regulate the transcriptional activity of the human. IFN-γ promoter in primary CD4+ lymphocytes. J Immunol 1998;160:3642-3648.